83 FR 5265 - Advisory Committee on Heritable Disorders in Newborns and Children
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 83, Issue 25 (February 6, 2018)
Health Resources and Services Administration
Federal Register Volume 83, Issue 25 (February 6, 2018)
| Page Range | 5265-5265 | |
| FR Document | 2018-02306 |
[Federal Register Volume 83, Number 25 (Tuesday, February 6, 2018)] [Notices] [Page 5265] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-02306] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Heritable Disorders in Newborns and Children AGENCY: Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice; correction. ----------------------------------------------------------------------- SUMMARY: This notice announces a correction to the meeting announcement for a public meeting of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC), published in the Federal Register on January 22, 2018. The meeting has changed from a two-day meeting to a one-day meeting, to be held on Thursday, February 8, 2018. Agenda items have been updated and will include a final evidence-based review report on the spinal muscular atrophy (SMA) condition nomination for possible inclusion on the Recommended Uniform Screening Panel (RUSP). Following this report, the ACHDNC expects to vote on whether to recommend adding SMA to the RUSP to the Secretary of HHS. The agenda will also include presentation of a document on cutoff determinations and risk assessment methods used for dried bloodspot newborn screening. The Committee expects to vote on whether to support this document. The ACHDNC members will also consider a report on Quality Measures in Newborn Screening from the Follow up and Treatment Workgroup. HRSA will post the agenda two days prior to the meeting on the Committee's website: https://www.hrsa.gov/advisory-committees/heritable-disorders/index.html. Please note that agenda items are subject to changes as priorities dictate. DATES: Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET (meeting time is tentative). ADDRESSES: The address for the meeting is 5600 Fishers Lane, 5th Floor Pavilion, Rockville, MD 20857. Participants may also access the meeting through Webcast. Advanced registration is required. Please register online at http://www.achdncmeetings.org/ by 12:00 p.m. ET on February 5, 2018. Instructions on how to access the meeting via Webcast will be provided upon registration. Please note that the 5600 Fishers Lane building requires security screening on entry. Visitors must provide a driver's license, passport, or other form of government-issued photo identification or they cannot enter the facility. Per the original meeting notice, non-US Citizens planning to attend in person had to provide additional information to HRSA by January 24, 2018, 12:00 p.m. Eastern Time. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACHDNC should contact Ann Ferrero, Maternal and Child Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to the following address: Ann Ferrero, MCHB, HRSA 5600 Fishers Lane, Room 18N100C, Rockville, MD 20857; (2) call 301-443-3999; or (3) send an email to: [email protected]. Correction: Date and time of the ACHDNC's public meeting. The meeting will now be held on Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018-02306 Filed 2-5-18; 8:45 am] BILLING CODE 4165-15-P
![Federal Register / Vol. 83, No. 25 / Tuesday, February 6, 2018 / Notices 5265
list of vaccines for administration to one-day meeting, to be held on will now be held on Thursday, February
vaccine-eligible children through the Thursday, February 8, 2018. Agenda 8, 2018, from 8:30 a.m. to 3:00 p.m. ET.
Vaccines for Children (VFC) program, items have been updated and will
Amy McNulty,
along with schedules regarding dosing include a final evidence-based review
interval, dosage, and contraindications Acting Director, Division of the Executive
report on the spinal muscular atrophy Secretariat.
to administration of vaccines. Further, (SMA) condition nomination for
[FR Doc. 2018–02306 Filed 2–5–18; 8:45 am]
under provisions of the Affordable Care possible inclusion on the Recommended
Act, section 2713 of the Public Health BILLING CODE 4165–15–P
Uniform Screening Panel (RUSP).
Service Act, immunization Following this report, the ACHDNC
recommendations of the ACIP that have expects to vote on whether to DEPARTMENT OF HEALTH AND
been approved by the Director of the recommend adding SMA to the RUSP to HUMAN SERVICES
Centers for Disease Control and the Secretary of HHS. The agenda will
Prevention and appear on CDC also include presentation of a document National Institutes of Health
immunization schedules must be on cutoff determinations and risk
covered by applicable health plans. assessment methods used for dried National Institute on Minority Health
Matters To Be Considered: The agenda bloodspot newborn screening. The and Health Disparities; Notice of
will include discussions on Influenza Committee expects to vote on whether Closed Meeting
vaccines, evidence based to support this document. The ACHDNC
recommendations, anthrax vaccine, Pursuant to section 10(d) of the
members will also consider a report on Federal Advisory Committee Act, as
Japanese encephalitis vaccines, hepatitis
Quality Measures in Newborn Screening amended, notice is hereby given of the
vaccines, human papillomavirus
from the Follow up and Treatment following meeting.
vaccines, pneumococcal vaccines,
Workgroup. HRSA will post the agenda The meeting will be closed to the
meningococcal disease, and an update
two days prior to the meeting on the public in accordance with the
on vaccines and other biologics for
Committee’s website: https:// provisions set forth in sections
prevention and treatment of healthcare-
associated infections. A www.hrsa.gov/advisory-committees/ 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
recommendation vote is scheduled for heritable-disorders/index.html. Please as amended. The grant applications and
hepatitis vaccines and evidence based note that agenda items are subject to the discussions could disclose
recommendations. Agenda items are changes as priorities dictate. confidential trade secrets or commercial
subject to change as priorities dictate. DATES: Thursday, February 8, 2018, property such as patentable materials,
The Director, Management Analysis from 8:30 a.m. to 3:00 p.m. ET (meeting and personal information concerning
and Services Office, has been delegated time is tentative). individuals associated with the grant
the authority to sign Federal Register applications, the disclosure of which
notices pertaining to announcements of ADDRESSES: The address for the meeting would constitute a clearly unwarranted
meetings and other committee is 5600 Fishers Lane, 5th Floor Pavilion, invasion of personal privacy.
management activities, for both the Rockville, MD 20857. Participants may
Name of Committee: National Institute on
Centers for Disease Control and also access the meeting through Minority Health and Health Disparities
Prevention and the Agency for Toxic Webcast. Advanced registration is Special Emphasis Panel; Special Emphasis
Substances and Disease Registry. required. Please register online at http:// Panel (R13) Conferences Grants.
www.achdncmeetings.org/ by 12:00 p.m. Date: March 16, 2018.
Elaine L. Baker, Time: 1:00 p.m. to 4:00 p.m.
ET on February 5, 2018. Instructions on
Director, Management Analysis and Services how to access the meeting via Webcast Agenda: To review and evaluate grant
Office, Centers for Disease Control and applications.
will be provided upon registration.
Prevention. Place: National Institutes of Health
[FR Doc. 2018–02268 Filed 2–5–18; 8:45 am] Please note that the 5600 Fishers Lane NIMHD, 7201 Wisconsin Ave., Suite 533,
BILLING CODE 4163–18–P
building requires security screening on Bethesda, MD 20814.
entry. Visitors must provide a driver’s Contact Person: Richard C. Palmer, DRPH,
license, passport, or other form of Health Scientist Administrator, National
government-issued photo identification Institute on Minority Health and Health
DEPARTMENT OF HEALTH AND Disparities, National Institutes of Health,
HUMAN SERVICES or they cannot enter the facility. Per the 7201 Wisconsin Ave, Bethesda, MD 20814,
original meeting notice, non-US Citizens (301) 451–2432, richard.palmer@nih.gov.
Health Resources and Service planning to attend in person had to
Administration provide additional information to HRSA Dated: January 31, 2018.
by January 24, 2018, 12:00 p.m. Eastern David Clary,
Advisory Committee on Heritable Time. Program Analyst, Office of Federal Advisory
Disorders in Newborns and Children Committee Policy.
FOR FURTHER INFORMATION CONTACT: [FR Doc. 2018–02279 Filed 2–5–18; 8:45 am]
AGENCY: Health Resources and Service Anyone requesting information
Administration (HRSA), Department of BILLING CODE 4140–01–P
regarding the ACHDNC should contact
Health and Human Services (HHS). Ann Ferrero, Maternal and Child Health
ACTION: Notice; correction. Bureau (MCHB), HRSA, in one of three DEPARTMENT OF HEALTH AND
SUMMARY: This notice announces a ways: (1) Send a request to the following HUMAN SERVICES
daltland on DSKBBV9HB2PROD with NOTICES
correction to the meeting announcement address: Ann Ferrero, MCHB, HRSA
for a public meeting of the Advisory 5600 Fishers Lane, Room 18N100C, National Institutes of Health
Committee on Heritable Disorders in Rockville, MD 20857; (2) call 301–443–
3999; or (3) send an email to: AFerrero@ Center for Scientific Review; Notice of
Newborns and Children (ACHDNC), Closed Meetings
published in the Federal Register on hrsa.gov.
January 22, 2018. The meeting has Correction: Date and time of the Pursuant to section 10(d) of the
changed from a two-day meeting to a ACHDNC’s public meeting. The meeting Federal Advisory Committee Act, as
VerDate Sep<11>2014 19:02 Feb 05, 2018 Jkt 244001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\06FEN1.SGM 06FEN1](https://thefederalregister.org/doc/83_FR_5290/page/1.svg)
Document Created: 2018-02-06 00:30:28
Document Modified: 2018-02-06 00:30:28
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice; correction. | |
| Dates | Thursday, February 8, 2018, from 8:30 a.m. to 3:00 p.m. ET (meeting time is tentative). | |
| Contact | Anyone requesting information regarding the ACHDNC should contact Ann Ferrero, Maternal and Child Health Bureau (MCHB), HRSA, in one of three ways: (1) Send a request to | |
| FR Citation | 83 FR 5265 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR